1. Home
  2. MNOV vs SCWO Comparison

MNOV vs SCWO Comparison

Compare MNOV & SCWO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNOV
  • SCWO
  • Stock Information
  • Founded
  • MNOV 2000
  • SCWO 2021
  • Country
  • MNOV United States
  • SCWO United States
  • Employees
  • MNOV N/A
  • SCWO N/A
  • Industry
  • MNOV Biotechnology: Pharmaceutical Preparations
  • SCWO Environmental Services
  • Sector
  • MNOV Health Care
  • SCWO Utilities
  • Exchange
  • MNOV Nasdaq
  • SCWO Nasdaq
  • Market Cap
  • MNOV 91.7M
  • SCWO 64.3M
  • IPO Year
  • MNOV 2005
  • SCWO N/A
  • Fundamental
  • Price
  • MNOV $1.90
  • SCWO $0.41
  • Analyst Decision
  • MNOV Strong Buy
  • SCWO
  • Analyst Count
  • MNOV 1
  • SCWO 0
  • Target Price
  • MNOV $9.00
  • SCWO N/A
  • AVG Volume (30 Days)
  • MNOV 21.3K
  • SCWO 401.3K
  • Earning Date
  • MNOV 02-18-2025
  • SCWO 03-28-2025
  • Dividend Yield
  • MNOV N/A
  • SCWO N/A
  • EPS Growth
  • MNOV N/A
  • SCWO N/A
  • EPS
  • MNOV N/A
  • SCWO N/A
  • Revenue
  • MNOV N/A
  • SCWO $313,930.00
  • Revenue This Year
  • MNOV N/A
  • SCWO N/A
  • Revenue Next Year
  • MNOV N/A
  • SCWO $5,180.00
  • P/E Ratio
  • MNOV N/A
  • SCWO N/A
  • Revenue Growth
  • MNOV N/A
  • SCWO N/A
  • 52 Week Low
  • MNOV $1.12
  • SCWO $0.36
  • 52 Week High
  • MNOV $2.55
  • SCWO $1.99
  • Technical
  • Relative Strength Index (RSI)
  • MNOV 45.15
  • SCWO 23.40
  • Support Level
  • MNOV $1.87
  • SCWO $0.54
  • Resistance Level
  • MNOV $2.06
  • SCWO $0.58
  • Average True Range (ATR)
  • MNOV 0.08
  • SCWO 0.06
  • MACD
  • MNOV 0.00
  • SCWO -0.00
  • Stochastic Oscillator
  • MNOV 47.48
  • SCWO 17.29

About MNOV Medicinova Inc

MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.

About SCWO 374Water Inc.

374Water Inc offers a technology that transforms wet wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., PFAS) into recoverable resources by focusing on waste as a valuable resource for water, energy, and minerals. The business activities of the company include manufacturing processes and waste recycling and treatment processes, which currently involve the use, treatment, storage, transfer, handling and/or disposal of hazardous materials, chemicals and wastes.

Share on Social Networks: